Want to see SE:ATT full AI Analyst Report?
Top Page
Attendo AB
(ATT)
Select Model
Select Model
Rating:63Neutral
Price Target:
kr124.00
▲(13.45% Upside)
Action:Reiterated
Date:05/09/26
The score is primarily driven by improving profitability and strong free-cash-flow generation, offset by elevated leverage and a major TTM revenue decline that raises near-term business quality concerns. Technicals are supportive with a clear uptrend and neutral momentum, while valuation is roughly mid-range with a low dividend yield.
Positive Factors
Free Cash Flow Generation
Free cash flow has been consistently strong (FCF roughly ~85–94% of net income across periods). Durable FCF close to reported earnings supports reinvestment in care units, working-capital flexibility and the ability to service debt or fund strategic initiatives over the next 2–6 months.
Negative Factors
High Leverage
Elevated leverage materially limits financial flexibility, increases interest-rate sensitivity and raises refinancing risk. With debt near ~2.9x equity, the company has less optionality for investments or acquisitions and is more vulnerable if operating cash flows weaken.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Generation
Free cash flow has been consistently strong (FCF roughly ~85–94% of net income across periods). Durable FCF close to reported earnings supports reinvestment in care units, working-capital flexibility and the ability to service debt or fund strategic initiatives over the next 2–6 months.
Read all positive factors
Attendo AB (ATT) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr16.49B
Dividend Yield0.82%
Average Volume (3M)307.31K
Price to Earnings (P/E)18.4
Beta (1Y)0.53
Revenue Growth-2.19%
EPS Growth76.78%
CountrySE
Employees33,000
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)5.93
Shares Outstanding151,196,120
10 Day Avg. Volume430,436
30 Day Avg. Volume307,315
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)2.24
Price to Sales (P/S)0.64
P/FCF Ratio4.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.95
Revenue Forecast (FY)kr19.05B
Attendo AB Business Overview & Revenue Model
Company Description
Attendo AB is a Nordic care services provider operating primarily in Sweden and Finland. The company delivers publicly funded welfare services, including elderly care (e.g., nursing homes and home care), care for people with disabilities (e.g., gr...
How the Company Makes Money
Attendo makes money by delivering care services that are predominantly financed by the public sector. Its main revenue model is service provision under (1) municipal or regional procurement contracts/tenders and framework agreements, and/or (2) au...
Attendo AB Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
48
Neutral
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.91B | 18.99B | 18.98B | 17.29B | 14.50B | 12.87B |
| Gross Profit | 4.34B | 3.20B | 8.20B | 5.92B | 1.52B | 1.42B |
| EBITDA | 3.95B | 3.87B | 3.44B | 3.05B | 2.18B | 1.99B |
| Net Income | 875.00M | 813.00M | 450.00M | 376.00M | -45.00M | 56.00M |
Balance Sheet | ||||||
| Total Assets | 24.39B | 25.05B | 25.24B | 22.89B | 22.32B | 21.08B |
| Cash, Cash Equivalents and Short-Term Investments | 733.00M | 1.27B | 821.00M | 922.00M | 507.00M | 513.00M |
| Total Debt | 15.83B | 16.44B | 16.74B | 14.75B | 14.80B | 13.88B |
| Total Liabilities | 18.93B | 19.60B | 19.91B | 17.53B | 17.32B | 16.12B |
| Stockholders Equity | 5.45B | 5.45B | 5.33B | 5.36B | 5.00B | 4.93B |
Cash Flow | ||||||
| Free Cash Flow | 2.80B | 2.65B | 2.26B | 2.08B | 1.13B | 1.21B |
| Operating Cash Flow | 2.99B | 2.85B | 2.46B | 2.23B | 1.33B | 1.38B |
| Investing Cash Flow | -196.00M | -330.00M | -1.24B | -185.00M | -390.00M | -413.00M |
| Financing Cash Flow | -2.53B | -2.04B | -1.33B | -1.63B | -970.00M | -1.18B |
Attendo AB Technical Analysis
Negative
109.30
Price Trends
113.14
Negative
108.70
Negative
97.04
Positive
Market Momentum
-1.13
Positive
42.54
Neutral
47.09
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ATT, the sentiment is Negative. The current price of 109.3 is below the 20-day moving average (MA) of 110.55, below the 50-day MA of 113.14, and above the 200-day MA of 97.04, indicating a neutral trend. The MACD of -1.13 indicates Positive momentum. The RSI at 42.54 is Neutral, neither overbought nor oversold. The STOCH value of 47.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ATT.
Attendo AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | kr8.27B | 34.20 | 16.15% | ― | 18.53% | 20.60% | |
71 Outperform | kr1.76B | 33.57 | ― | ― | 3.23% | -63.00% | |
71 Outperform | kr3.03B | 17.85 | 5.55% | 2.18% | -3.48% | -14.02% | |
68 Neutral | kr10.91B | 16.88 | 13.73% | 1.89% | 15.74% | 15.67% | |
65 Neutral | kr1.64B | 39.44 | ― | ― | ― | ― | |
63 Neutral | kr16.49B | 18.45 | ― | 0.82% | -2.19% | 76.78% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
SE:ATT
Attendo AB
108.70
39.90
57.99%
SE:HUM
Humana AB
62.40
25.99
71.38%
SE:AMBEA
Ambea AB
143.40
25.66
21.80%
SE:MCAP
MedCap AB
551.50
-118.50
-17.69%
SE:SUS
Surgical Science Sweden AB
35.48
-106.12
-74.94%
SE:CARA
Carasent AB
24.45
-5.15
-17.40%
Attendo AB Corporate Events
Attendo Survey Shows Broad Political Backing to Scrap Minute-Based Home Care Scheduling
Jul 8, 2026
A new survey commissioned by Attendo shows that 77 percent of local politicians across Sweden want to abolish minute-by-minute scheduling in home care, a model where municipalities pre-allocate time for each task down to the minute. The findings r...
Attendo Steps Up Nordic Care Group Buyback Program With SEK 17.7m Weekly Repurchases
Jul 7, 2026
Attendo AB has continued to execute its share repurchase program, buying back 150,000 shares on Nasdaq Stockholm during week 27 at a total transaction value of about SEK 17.7 million. The program, which is capped at SEK 275 million and runs throug...
Attendo bolsters southern Sweden footprint with Skåningegård acquisition
Jul 1, 2026
Attendo AB has completed the acquisition of Skåningegård-gruppen, a family-owned Swedish care provider with nine units across Östergötland, Kalmar, Kronoberg, Småland and Gotland, strengthening its presence in southern Swe...
Attendo CEO Martin Tivéus to Step Down After Eight Years, Strategy Unchanged
Jun 30, 2026
Attendo AB, the Nordic region’s largest private care provider, operates a broad network of care units across Finland, Sweden and Denmark, with its headquarters in Stockholm and a listing on Nasdaq Stockholm. The company’s business mode...
Attendo Accelerates Share Buybacks Under SEK 275m Repurchase Program
Jun 30, 2026
Attendo AB has continued executing its board-approved share repurchase program, buying back 150,000 shares on Nasdaq Stockholm between 22 and 26 June 2026. The week’s transactions, carried out by DNB Carnegie Investment Bank, were valued at ...
Attendo Steps Up Share Buybacks Under SEK 275 Million Programme
Jun 23, 2026
Attendo AB has continued its share buyback programme, repurchasing 120,000 shares over the week of 15–19 June 2026 on Nasdaq Stockholm at an average price of about SEK 110.38 per share. The transactions, executed by DNB Carnegie Investment B...
Attendo to Bolster Southern Sweden Care Network with Skåningegård Acquisition
Jun 18, 2026
Attendo AB is the leading Nordic care provider, offering elderly care, disability services and social care through about 770 units and 33,000 employees in Finland, Sweden and Denmark. Listed on Nasdaq Stockholm and based in Stockholm, the group fo...
Attendo Steps Up Share Buybacks, Tightening Free Float
Jun 16, 2026
Attendo AB has continued to execute its share buyback programme, repurchasing 175,000 shares on Nasdaq Stockholm during the week of 8–12 June 2026 for roughly SEK 20 million. The company has now acquired a total of 905,000 shares under the c...
Attendo Invests in New Vallentuna Nursing Home to Meet Future Elderly Care Demand
Jun 10, 2026
Attendo is deepening its presence in Vallentuna, outside Stockholm, with a long-term investment in elderly care that includes relocating the Vårdbo nursing home to larger, refurbished premises in central Vallentuna. The new 3,500-square-metre...
Attendo Steps Up Share Buybacks as Treasury Holdings Grow
Jun 9, 2026
Nordic care provider Attendo AB has continued its share buyback program, repurchasing 170,000 shares on Nasdaq Stockholm between 1 and 5 June 2026 at an average price of about SEK 111.79, for a total value of roughly SEK 19 million. The program, e...
Attendo Advances SEK 275 Million Share Buyback as Treasury Stock Rises
Jun 2, 2026
Attendo AB has continued its share buyback programme, repurchasing 175,000 shares on Nasdaq Stockholm between 25 and 29 May 2026 for a total of about SEK 20.5 million, at an average price of SEK 117.43 per share. The transactions, executed by DNB ...
Attendo Streamlines Capital Structure With Cancellation of Treasury Shares
May 29, 2026
Attendo AB, the Nordic region’s largest private care provider with extensive elderly and social care operations in Finland, Sweden and Denmark, continues to expand its role as a key partner to the public sector in tackling structural care ch...
Attendo Shares Trade Steadily in Narrow Range on Nasdaq Stockholm
May 12, 2026
Attendo AB reported detailed intraday trading data for its shares on Nasdaq Stockholm on 7 May 2026, showing multiple transactions throughout the trading day in the price range of roughly SEK 105.70 to SEK 107.40. The pattern indicates steady liqu...
Attendo AGM Backs Dividend, New Incentive Plans and Capital Changes
May 6, 2026
Attendo AB’s Annual General Meeting re-elected Ulf Mattsson as chair of a six-member board and appointed PwC as auditor until 2027, while approving the 2025 financial statements, remuneration report and releasing the board and CEO from liabi...
Attendo Launches SEK 275 Million Share Buyback to Optimize Capital Structure
May 6, 2026
Attendo’s board has approved a share buyback program of up to SEK 275 million, aiming to optimize the company’s capital structure and provide shares for existing incentive programs for employees and management. The repurchases, which w...
Attendo’s Unika expands specialised Prader–Willi care with new Mölndal unit
May 6, 2026
Attendo’s Unika brand, which consolidates its Swedish LSS disability services, has opened a new specialised unit in Mölndal for people with Prader–Willi syndrome, a rare condition requiring highly adapted support. The residence is...
Attendo Boosts Profitability on Higher Occupancy Despite Sales Dip
May 6, 2026
Attendo reported continued positive development across its business areas in the first quarter of 2026, driven by higher occupancy and improved operational efficiency, which helped lift adjusted earnings per share to 6.47 SEK on a rolling 12‑...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.